The rate of transcription of an individual gene is controlled by both positively acting and negatively acting (repressing) protein factors, which interact with regulatory sequences in the promoter or enhancer region of that gene. The precise mechanisms by which transcription factors exert either stimulating or repressing effects are still unclear and a focus of intense research. Results reported in a flurry of recent papers [1] [2] [3] [4] [5] [6] [7] have provided new insights into the mechanism of transcriptional repression; the new findings suggest that at least some repressors of transcription act by modifying the structure of the chromatin into which the gene is packed. More specifically, the idea is that repression involves the recruitment to a gene's promoter of histone deacetylases, enzymes that remove acetyl groups from specific lysines in the tails of histone H3 and H4. Repression is thus suggested to result from changes in the degree and stability of nucleosomal packaging.
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One of the proteins for which this mechanism is suggested is mammalian Mad-1. Mad-1 is one of a group of five closely related proteins -Mad-1, Mad-2 (Mxi-1), Mad-3, Mad-4 and Mnt (Rox) -that all have helix-loop-helix/leucine zipper domains and that bind to DNA and repress transcription as obligate heterodimers with a common partner protein known as Max. Max was discovered, however, not as a partner of Mad proteins, but by virtue of its ability to form heterodimers with Myc proteins; Max binds in a mutually exclusive manner to either Myc or Mad. Myc-Max complexes, in contrast to Mad-Max complexes, are activators of transcription; complex formation with Max is required for Myc to activate gene expression and transform cells. Mad proteins thus antagonize the transforming and mitogenic functions of Myc proteins by competing for binding to Max and to DNA. Together, the three groups of proteins form a small, evolutionarily conserved network that acts as a central regulator of proliferation and apoptosis in mammalian cells (for review, see [8] ).
For Mad proteins to repress transcription, two of their domains are of critical importance. One is the basic region/helix-loop-helix/leucine zipper domain required for both DNA binding and dimerization with Max. The second is a short, amino-terminal amphipathic helix: deletions or point mutations in this helix do not abolish DNA binding, but they do impair the ability of a Mad protein to repress transcription or suppress Myc-dependent transformation [9, 10] . Two mouse proteins that interact with Mad via this repression domain have been identified using the yeast two-hybrid cloning method; these are called mSin3A and mSin3B on account of their sequence similarity to the budding yeast Sin3 protein [9, 10] . Formation of a ternary Max-Mad-mSin3 complex can be demonstrated in vitro and in vivo, and mutations of Mad that disrupt complex formation with Sin3 lead to a loss of transcriptional repression. Strikingly, the Mad repression domain functions in yeast when tethered to a heterologous DNA-binding domain, and this repression is dependent on the presence of a wild-type SIN3 allele [11] . Taken together, these results show that Mad represses transcription via recruitment of mSin3.
The yeast SIN3 gene was first identified by a mutation that allows expression of the HO gene in the absence of its transcriptional activator, Swi5p [12, 13] . HO encodes an endonuclease required for the recombination at the MAT locus that causes mating-type switching. HO expression is restricted to the mother cells in a haploid lineage, but sin3 mutations derepress the HO gene in daughter cells, suggesting that the Sin3 protein is a negative regulator of HO transcription. However, sin3 mutations are not specific for HO gene expression -for example, they also allow expression of the meiotic genes, such as IME2, in the absence of their cognate activator and of starvation, the natural inducer of their expression [14] . Thus, Sin3 acts as a more general, but by no means universal, negative regulator of transcription. Studies in yeast have also established that SIN3 acts as part of a small genetic pathway; it is, for example, epistatic to an unrelated gene, RPD3, mutations of which have a very similar phenotype to sin3 mutations [14, 15] . The sequence of Sin3 revealed four paired amphipathic helix motifs, reminiscent of the helix-loop-helix domain, strongly suggesting that Sin3 acts at least in part by making multiple protein-protein interactions [16] .
As the next piece of the puzzle, two independent lines of research identified Rpd3 and a related mammalian protein as components of histone deacetylase complexes. In yeast, two distinct deacetylase complexes were identified, one of which, termed HDA, was purified, micro-sequenced and cloned. HDA turned out to contain a protein, Hda-1, that is closely related to Rpd3. Subsequently, Rpd3 itself was found to be a component of the second deacetylase complex, HDB [17] . In mammalian cells, purification of proteins that bind to trapoxin, a highly selective inhibitor of histone deacetylases, led to the identification of two proteins: Hdac1, related to Rpd3, and RbAP48, previously identified as a protein that interacts with the retinoblastoma protein (which can also repress cellular transcription) [18] . A mammalian homologue of Rpd3, termed Hdac2, was identified in a two-hybrid screen using YY-1, a transcriptional repressor as bait [19] . These findings suggested a model in which Mad proteins recruit Sin3 and thereby activate a pathway leading to histone deacetylation at Mad-Max binding sites. This prediction has now received firm support by the recent papers [1] [2] [3] [4] [5] [6] [7] , which further show that deacetylases are directly recruited by Sin3 to form a high molecular weight protein complex (Figure 1 ). While the individual papers provide a wealth of detailed information, they share a set of common conclusions.
The first is that immunoprecipitations with antibodies against mSin3 specifically co-immunoprecipitate both mammalian histone deacetylase proteins, Hdac1 and Hdac2, demonstrating that they are components of a common protein complex. This complex has histone deacetylase activity in vitro. Within Sin3, a specific domain has been identified that is required and sufficient for recruiting Hdac proteins. When tethered to a heterologous DNA-binding domain, this domain is sufficient to mediate repression of basal transcription, suggesting that Sin3 represses via recruitment of histone deacetylases. Further, Mad, Sin3 and Hdac2 can be shown to form a ternary complex that has histone deacetylase activity. Together, the data strongly suggest that Mad can recruit, via its interaction with mSin3, histone deacetylase activity to its target sites on DNA.
A twist in the story is introduced by the papers of Heinzel et al. [7] and Alland et al. [2] . In both, mSin3 is found to interact, not only with mRpd3, but also with N-CoR, a protein that was previously shown to mediate the repressive effects of non-liganded thyroid hormone receptor. Repression by Mad requires the function of all three proteins, mSin3, Rpd3 and N-CoR, as antibodies against each one impairs the ability of a GAL4-Mad fusion protein to repress a minimal promoter [7] . The interaction between Sin3 and N-CoR is direct, as it can be directed both in the two-hybrid assay and in vitro [2, 7] . This is in contrast to the interactions between either mSin3 or N-CoR and histone deacetylase, for which no direct interactions could be demonstrated (although they co-immunoprecipitate in vivo, as described above). The potential exception to this is in yeast, where Sin3 and Rpd3 interact in the twohybrid assay; however, the presence of endogenous yeast components in the complex is not excluded by the experiments. The data suggest that additional factors exist that help to assemble histone deacetylase complexes. Indeed, immunoprecipitations from metabolically labelled cells have show that there are additional proteins in these complexes, two of which, SAP18 and SAP30, are identified in the paper by Zhang et al. [1] .
What are the functional implications of these findings? Both Hassig et al. [4] and Laherty et al. [6] show that inhibitors of histone deacetylases partly revert repression by Mad proteins, arguing for a causal role of deacetylation in transcriptional repression [4, 6] . Sommer et al. [3] go one step further to show that deacetylase inhibitors impair the ability of Mad to inhibit cell proliferation upon microinjection in quiescent cells [3] . However, whether histones or other proteins involved in transcription are the actual targets for deacetylation is not yet clear. A note of caution is also warranted, as mutations in yeast deacetylases have complicated effects on gene expression and indeed lead to a loss of telomeric silencing [16] . Thus, no simple correlation holds between histone deacetylation and gene expression, and whether deacetylation of histone is really the driving force of repression must remain open.
Finally, if Mad proteins recruit histone deacetylases, do Myc proteins act by recruiting histone acetylases and opening chromatin? There is no direct evidence to support this notion. But as Alland et al. [2] point out, the present papers are not the first to draw a link between the function of Myc proteins and chromatin structure. Previously, one of the oncogenes that cooperate with myc in the genesis of B-cell lymphomas, bmi-1, has been found to encode a member of the polycomb family of proteins [20] . These chromatin proteins form multi-protein complexes that are thought to organize large chromatin domains within chromosomes and act as a molecular 'memory' during Drosophila development. If such proteins sense the presence or absence of histone acetylation, local changes in acetylation induced by Myc or Mad proteins might translate into long-lasting and stable changes in gene expression -such as one might expect to occur during differentiation -via their effects on the binding of polycomb group proteins. Potentially, then, the present papers provide a glimpse as to how the control of cellular proliferation by Myc proteins is linked to cellular differentiation.
